Skip to main content

Table 2 Utilization of services

From: Assessment of health services for people who use drugs in Central Asia: findings of a quantitative survey in Kazakhstan and Kyrgyzstan

  Kazakhstan Kyrgyzstan
  Group A (reg. PWUD) (%) Group B (non-reg. PWUD) (%) Group A (reg. PWUD) (%) Group B (non-reg. PWUD) (%)
  N = 301 N = 299 N = 450 N = 450
Utilization of nine interventions (ever)a
 HIV testing and counseling (T&C) 95.0 77.9* 97.1 62.4*
 Prevention, diagnosis, and treatment of tuberculosis (TB) 93.0 81.9* 94.2 65.8*
 Targeted information, education, and communication (IEC) for IDUs and their sexual partners 89.0 60.5* 95.3 63.8*
 Needle and syringe programs (NSPs) 71.4 45.2* 76.0 46.9*
 Opioid substitution therapy (OST) and other drug dependence treatment 80.7 15.7* 95.8 27.1*
 Condom programs for IDUs and their sexual partners 69.8 41.8* 81.6 47.6*
 Vaccination, diagnosis, and treatment of viral hepatitis 54.4 55.5 83.8 56.4*
 Prevention and treatment of sexually transmitted infections (STIs) 53.3 52.5 82.7 55.3*
 Antiretroviral therapy (ART)b 6.6 2.7* 9.6 6.2
 None of the above 0.3 10.7* 0.2 24.2*
Utilization of drug-related services (ever)a
 Detoxification without methadone 46.3 9.2* 23.6 13.2*
 Opioid substitution therapy 28.0 1.7* 90.4 0.4*
 Psychotherapy 20.7 7.8* 11.3 8.1
 Brief intervention/motivational interviewing/consulting 19.3 2.0* 11.6 8.7
 Social rehabilitation programs 13.0 2.0* 3.8 4.5
 Maintenance therapy with naltrexone or other opioid antagonist 11.3 5.1* 1.6 1.6
 Detoxification with methadone 9.7 1.0* 20.4 4.3*
 Relapse prevention training 7.0 1.0* 4.4 4.5
 Self-help groups (12-step program) 5.3 1.4* 8.0 10.1
 None of the above 19.0 84.0* 4.2 72.5*
  1. IDUs injecting drug users, PWUD people who use drugs
  2. *Indicates a significant result (p = 0.05 or smaller) between group A and group B in each country
  3. aMultiple response
  4. bDatabase: only HIV-infected PWUD